Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.
Lee JJ, Sholl LM, Lindeman NI, Granter SR, Laga AC, Shivdasani P, Chin G, Luke JJ, Ott PA, Hodi FS, Mihm MC, Lin JY, Werchniak AE, Haynes HA, Bailey N, Liu R, Murphy GF, Lian CG. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics. 2015; 7:59.
-
Christine Guo Lian, M.D.
-
Alvaro Christian Laga, M.D.
-
Neal I. Lindeman, M.D.
-
Martin Charles Mihm Jr., M.D.
-
Patrick Alexander Ott, Ph.D., M.D.
-
Scott R. Granter, M.D.
-
George Francis Murphy, M.D.
-
Jennifer Y. Lin, M.D.
-
Harley Anderson Haynes, M.D.
-
Lynette Marie Sholl, M.D.
-
Frank Stephen Hodi, M.D.